Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders (JY231 NID)

  • Authors : Daishi Tian, Professor

  • Source: An Early Exploratory Clinical Study of the Safety, Tolerability, and Preliminary Efficacy of JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

تفاصيل العنوان

×
Report

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

  • Source: A Phase 1B Study of IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Refractory Primary and Secondary Progressive Multiple Sclerosis

تفاصيل العنوان

×
Report

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Source: A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

تفاصيل العنوان

×
Report

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

  • Source: An Exploratory Study on the Safety and Efficacy of Universal CAR-T Cells Targeting BCMA and CD19 in the Treatment of Refractory Autoimmune

تفاصيل العنوان

×
Report

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Source: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other

تفاصيل العنوان

×
Report

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

  • Source: A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)Vaziri H, Turshudzhyan A, Vecchio E. Immunotherapy-induced

تفاصيل العنوان

×
Report

A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases

  • Source: A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Severe, Refractory

تفاصيل العنوان

×
Report

Apremilast Pregnancy Exposure Registry

  • Source: Apremilast Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

تفاصيل العنوان

×
Report

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

  • Source: Stelara® and Tremfya® Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project

تفاصيل العنوان

×
Report

OTIS Cimzia Pregnancy Registry

  • Source: Cimzia (certolizumab Pegol) Pregnancy Exposure Registry: OTIS Autoimmune Diseases in Pregnancy Project

تفاصيل العنوان

×
  • 1-10 ل  581 نتائج ل ""Autoimmune Diseases""